Effects of differences in dose and frequency of teriparatide on bone structure in Proximal Femur. – Analysis by DXA-based 3D-modeling (3D-SHAPER Software) –TRIPLE-BONE study (The effects of TeRIParatide preparation on bone mineraL density increase and BONE structure)
- 2 July 2024
- journal article
- research article
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 19 (1) , 55
Abstract
Trends toward more favorable improvement of the cortical bone parameters by once-weekly (56.5 mu g once a week) and twice-weekly teriparatide (28.2 mu g twice a week), and that of the trabecular bone parameters by once-daily (1/D) teriparatide (20 mu g/day once a day) were shown. Purpose To examine the effects of differences in the amount of teriparatide (TPTD) per administration and its dosing frequency on the bone structure in the proximal femur by dual-energy X-ray absorptiometry (DXA)-based 3D-modeling (3D-SHAPER software). Methods This was a multicenter retrospective study. Patients aged 50 years or older with primary osteoporosis who continuously received once-/twice-weekly (1.2/W, n = 60) or 1/D TPTD (n = 14) administration for at least one year were included in the study. Measurement regions included the femoral neck (FN), trochanter (TR), femoral shaft (FS), and total proximal hip (TH). Concurrently, the bone mineral density (BMD) and Trabecular Bone Score (TBS) were measured. Results The cross-sectional area, cross-sectional moment of inertia, and section modulus in the FS were significantly improved in the 1.2/W TPTD group, as compared to the 1/D TPTD group. However, significant improvement of the cortical thickness and buckling ratio in the FN was observed in the 1/D TPTD group, as compared to the 1.2/W TPTD group. Trabecular BMD values in the FS and TH were significantly increased in the 1/D TPTD group, as compared to the 1.2/W TPTD group, while the cortical BMD values in the TR, FS, and TH were significantly increased in the 1.2/W TPTD group, as compared to the 1/D TPTD group. ConclusionTrends toward more favorable improvement of the cortical bone by 1.2/W TPTD and that of the trabecular bones by 1/D TPTD were observed.Keywords
This publication has 25 references indexed in Scilit:
- Predictive ability of novel volumetric and geometric indices derived from dual-energy X-ray absorptiometric images of the proximal femur for hip fracture compared with conventional areal bone mineral density: the Japanese Population-based Osteoporosis (JPOS) Cohort StudyOsteoporosis International, 2021
- A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05Osteoporosis International, 2021
- Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modelingOsteoporosis International, 2021
- Comparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort studyOsteoporosis International, 2021
- Trends in Hip Fracture Incidence in Japan: Estimates Based on Nationwide Hip Fracture Surveys From 1992 to 2017JBMR Plus, 2020
- Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE studyOsteoporosis International, 2019
- Effects of osteoporosis drug treatments on cortical and trabecular bone in the femur using DXA-based 3D modelingOsteoporosis International, 2018
- Diagnostic criteria for primary osteoporosis: year 2012 revisionJournal of Bone and Mineral Metabolism, 2013
- Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summaryArchives of Osteoporosis, 2012
- Structural trends in the aging proximal femur in Japanese postmenopausal womenBone, 2007